Blytheweigh supports World High Life’s IPO and acquisition of Love Hemp Ltd
With the support of Blytheweigh (“Bw”), World High Life Plc, a CBD and medicinal cannabis investment vehicle, completed a successful IPO and listed onto the NEX Exchange Growth Market on 12th September 2019.
World High Life’s investment strategy will focus on markets that are internationally recognised as having well-developed and reputable laws and regulations relating to the research and production of medicinal cannabis, hemp and CBD, as well as therapeutic Cannabis derivatives including, but not limited to, nutraceuticals, dietary supplements and cosmetic products. The Directors believe that there are numerous investment opportunities within the CBD wellness industry, the hemp industry and the medicinal cannabis industry.
Since listing, the Company has successfully closed the acquisition of Love Hemp Ltd, one of the UK’s leading CBD and Hemp product suppliers with more than 40 product lines, comprising oils, sprays and vapes and a variety of edible and water-based CBD products. The Company's Directors believe that this first investment by the Company provides World High Life with a platform to expand Love Hemp's already significant business throughout the UK and more extensively into Europe.
Camilla Horsfall, Director of Bw, commented:
“We are very proud to have been able to help bring World High Life to the market. We believe that the company has huge potential in the European CBD and wellness industry and are excited to share its story.”
Tim Blythe, Camilla Horsfall or Megan Ray on 020 7138 3204